🟢 92/100

This product looks safe

  • Folic Acid: 400mg is 400.0× the Tolerable Upper Intake Level (1.0mg)
  • 80% of ingredients have research evidence
C Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Folic Acid: 400mg is 400.0× the Tolerable Upper Intake Level (1.0mg)

Label Data

1 Bottle(s) Serving Size
1 Servings
Other Combinations Product Type
80% Evidence Coverage

Supplement Facts — Evidence Check

32 mg (200% DV)
✅ 2.3× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 32mg UL 35mg
34 mg (2000% DV)
📊 26.2× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 34mg UL 100mg
400 mcg DFE (100% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 400.0× (UL: 1.0 mg) 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 400mg UL 1.0mg
200 mcg (8333% DV)
📊 83.3× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.2mg
Energy Blend
2000 mg

Other Ingredients

Water Potassium Citrate Natural Flavors Potassium Benzoate Potassium Sorbate Sucralose Calcium Disodium EDTA

Label Claims — Verification

Nutrient
All Other
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Recommended use: Drink one whole bottle (2 fluid ounces) for maximum energy. Do not exceed one bottle daily, consumed several hours apart. Use or discard any remainder within 72 hours (3 days) after opening.

⚠️ Warnings & Precautions

Tamper Evident Seal Caution: Limit caffeine products to avoid nervousness, sleeplessness, and occasional rapid heartbeat. You may experience a niacin flush (hot feeling, skin redness) that lasts a few minutes. This is caused by increased blood flow near the skin. Not recommended for pregnant or breastfeeding women, children, or those sensitive to caffeine. Caffeine content: 200 mg / 2 fl. oz.

Not recommended for pregnant or breastfeeding women, children, or those sensitive to caffeine.

Not recommended for pregnant or breastfeeding women, children, or those sensitive to caffeine. Keep out of reach of children.

Do not use if sleeve is broken or missing.

🧪 Formulation Notes

Berry flavored with other natural flavors B-Vitamins and Amino Acid

Additional Information

Refrigeration not required.

Product Details

UPC / SKU 8 42379 14915 3
DSLD Entry Date 2024-07-25
Product Type Other Combinations
Form Liquid
Brand Solimo
DSLD ID 310548
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →